title: Thalidomide therapy in compensated and decompensated myelofibrosis with myeloid metaplasia.
authors.forename: G
authors.initials: G
authors.lastname: Pozzato
authors.forename: F
authors.initials: F
authors.lastname: Zorat
authors.forename: F
authors.initials: F
authors.lastname: Nascimben
authors.forename: C
authors.initials: C
authors.lastname: Comar
authors.forename: F
authors.initials: F
authors.lastname: Kikic
authors.forename: G
authors.initials: G
authors.lastname: Festini
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage* / Q000592:standards / Q000633:toxicity; D001853:Bone Marrow / Q000473:pathology; D004341:Drug Evaluation; D006801:Humans; D009389:Neovascularization, Pathologic / Q000188:drug therapy; D055728:Primary Myelofibrosis / Q000150:complications / Q000188:drug therapy* / Q000209:etiology; D013792:Thalidomide / Q000008:administration & dosage* / Q000592:standards / Q000633:toxicity
chemical_list: D020533:Angiogenesis Inhibitors; D013792:Thalidomide